After treatment with semaglutide, newly diagnosed Type 1 diabetes patients needed little or no insulin

Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

Related Keywords

United States ,American ,Husama Ghanim ,Ajay Chaudhuri ,Paresh Dandona ,Biomedical Sciences ,Ub Clinical Research Center ,American Diabetes Association Hb ,University At Buffalo ,Jacobs School ,Jacobs School Of Medicine ,New England Journal ,Research Center ,American Diabetes Association ,Treat Type ,Niagara Paper ,Iagara County Publication ,Erie County ,Iagara Wheatfield Tribune ,Rand Island Pennysaver ,Rand Island Dispatch Lewiston Porter Sentinel , ,